Search research articles
Contact Us
Filters
Showing results (831-840 of 4,265) with videos related to
Page
of 427
Sort By:
Cancer Discovery
|
November 13, 2021
Ibrutinib with R-CHOP Differentially Affects Genetic Subtypes of DLBCL
Cancer Discovery
|
November 16, 2021
Exome Sequencing IDs Hidden Disease Variants
Cancer Discovery
|
October 30, 2012
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors
Janneke E Jaspers, Ariena Kersbergen, Ute Boon, et al.
Cancer Discovery
|
October 30, 2012
Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling
Amy Young, David Lou, Frank McCormick
Cancer Discovery
|
January 10, 2014
Faulty ECM signaling facilitates autoimmune lymphomagenesis
Rolf A Brekken
Cancer Discovery
|
January 10, 2014
Towards a unified model of RAF inhibitor resistance
David B Solit, Neal Rosen
Cancer Discovery
|
January 10, 2014
ASCO forges ahead with CancerLinQ
Cancer Discovery
|
November 14, 2012
Fingerprinting acute leukemia: DNA methylation profiling of B-acute lymphoblastic leukemia
Luisa Cimmino, Iannis Aifantis
Cancer Discovery
|
January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
Jack F Shern, Li Chen, Juliann Chmielecki, et al.
Cancer Discovery
|
November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation
Anna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.
Page
of 427
Search research articles
Search
Showing results (831-840 of 4,265) with videos related to
Sort By:
Page
of 427
Cancer Discovery
|
November 13, 2021
Ibrutinib with R-CHOP Differentially Affects Genetic Subtypes of DLBCL
Cancer Discovery
|
November 16, 2021
Exome Sequencing IDs Hidden Disease Variants
Cancer Discovery
|
October 30, 2012
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors
Janneke E Jaspers, Ariena Kersbergen, Ute Boon, et al.
Cancer Discovery
|
October 30, 2012
Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling
Amy Young, David Lou, Frank McCormick
Cancer Discovery
|
January 10, 2014
Faulty ECM signaling facilitates autoimmune lymphomagenesis
Rolf A Brekken
Cancer Discovery
|
January 10, 2014
Towards a unified model of RAF inhibitor resistance
David B Solit, Neal Rosen
Cancer Discovery
|
January 10, 2014
ASCO forges ahead with CancerLinQ
Cancer Discovery
|
November 14, 2012
Fingerprinting acute leukemia: DNA methylation profiling of B-acute lymphoblastic leukemia
Luisa Cimmino, Iannis Aifantis
Cancer Discovery
|
January 18, 2014
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
Jack F Shern, Li Chen, Juliann Chmielecki, et al.
Cancer Discovery
|
November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation
Anna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.
Page
of 427